We are live on ! Find out more
KRRO icon

Korro Bio

43 hedge funds and large institutions have $2.52M invested in Korro Bio in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

0.14% less ownership

Funds ownership: 0.42%0.28% (-0.14%)

12% less funds holding

Funds holding: 4943 (-6)

29% less call options, than puts

Call options by funds: $37K | Put options by funds: $52K

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

91% less capital invested

Capital invested by funds: $28.1M → $2.52M (-$25.6M)

Holders
43
Holders Change
-6
Holders Change %
-12.24%
% of All Funds
0.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
11
Reduced
7
Closed
13
Calls
$37K
Puts
$52K
Net Calls
-$15K
Net Calls Change
-$242K
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
51
Jane Street
New York
-$38.6K -201 Closed
TIM
52
Tortoise Investment Management
New York
-$38.5K -200 Closed
Fidelity Investments
53
Fidelity Investments
Massachusetts
-$2.13K -11 Closed
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
+$1.37K +12 New

KRRO Hedge Fund Activity: Q1 2023 in Review

43 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q1 2023, worth a combined $2.52M — down 91% from $28.1M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of KRRO and 7 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 11 added.

The largest buyer was Acadian Asset Management, opening a new position worth an estimated $321K. The largest seller was Federated Hermes, exiting entirely with an estimated $5.05M sold.

  • 43 institutional investors held Korro Bio (KRRO) as of Q1 2023, down from 49 in Q4 2022.
  • Funds reported $2.52M of Korro Bio stock for Q1 2023, down 91% quarter-over-quarter.
  • 7 funds opened new Korro Bio positions in Q1 2023 and 13 closed out, a net change of -6 holders.
  • The largest Korro Bio buyer in Q1 2023 was Acadian Asset Management, an estimated $321K added.
  • The largest Korro Bio seller in Q1 2023 was Federated Hermes, an estimated $5.05M sold.

Based on aggregated 13F filings for Q1 2023.